Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K I Johnson

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Pharmacoeconomics|September 30, 2000
Long-term treatment of multiple sclerosis with interferon-beta may be cost effectiveM Kendrick, K I Johnson
Arzneimittel-Forschung|January 1, 1984
[The effect of cimetidine on the metabolism and effects of alcohol]K I Johnson, E Fenzl, B Hein
Arzneimittel-Forschung|January 1, 1981
Relationship between the pharmacodynamics and pharmacokinetics of two oral sustained-release formulations of isosorbide dinitrate in normal manK I Johnson, V Gladigau, K Schnelle
Arzneimittel-Forschung|January 1, 1984
Relative bioavailability of etofibrate. A comparison of an acute and a new sustained release formulationK I Johnson, H J Hoppe, W Schatton
The Journal of Burn Care & Rehabilitation|January 1, 1988
Strategies to improve burn center utilizationK I Johnson, A A Meyer, S K Evans
Arzneimittel-Forschung|January 1, 1981
Finger pulse plethysmographic effects of two oral sustained-release formulations of isosorbide dinitrate in normal manK Schnelle, E Fenzl, K I Johnson, et al.
Arzneimittel-Forschung|January 1, 1985
An early phase I study to determine the tolerance, safety and pharmacokinetics of idebenone following multiple oral dosesM F Barkworth, C J Dyde, K I Johnson, et al.
Arzneimittel-Forschung|January 1, 1981
Plasma levels of isosorbide dinitrate and its main metabolites following oral administration of two sustained release formulations in normal manV Gladigau, G Neurath, M Dünger, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 1, 1983
Disposition of 14C-loprazolam in animals and manH P Illing, R M Ings, K I Johnson, et al.
Arzneimittel-Forschung|January 1, 1983
[Comparative studies on biologic availability and pharmacokinetics of bromazepam in tablets]O von Stetten, K D Rehm, E Fenzl, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Pharmacoeconomics|September 30, 2000
Long-term treatment of multiple sclerosis with interferon-beta may be cost effectiveM Kendrick, K I Johnson
Arzneimittel-Forschung|January 1, 1984
[The effect of cimetidine on the metabolism and effects of alcohol]K I Johnson, E Fenzl, B Hein
Arzneimittel-Forschung|January 1, 1981
Relationship between the pharmacodynamics and pharmacokinetics of two oral sustained-release formulations of isosorbide dinitrate in normal manK I Johnson, V Gladigau, K Schnelle
Arzneimittel-Forschung|January 1, 1984
Relative bioavailability of etofibrate. A comparison of an acute and a new sustained release formulationK I Johnson, H J Hoppe, W Schatton
The Journal of Burn Care & Rehabilitation|January 1, 1988
Strategies to improve burn center utilizationK I Johnson, A A Meyer, S K Evans
Arzneimittel-Forschung|January 1, 1981
Finger pulse plethysmographic effects of two oral sustained-release formulations of isosorbide dinitrate in normal manK Schnelle, E Fenzl, K I Johnson, et al.
Arzneimittel-Forschung|January 1, 1985
An early phase I study to determine the tolerance, safety and pharmacokinetics of idebenone following multiple oral dosesM F Barkworth, C J Dyde, K I Johnson, et al.
Arzneimittel-Forschung|January 1, 1981
Plasma levels of isosorbide dinitrate and its main metabolites following oral administration of two sustained release formulations in normal manV Gladigau, G Neurath, M Dünger, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 1, 1983
Disposition of 14C-loprazolam in animals and manH P Illing, R M Ings, K I Johnson, et al.
Arzneimittel-Forschung|January 1, 1983
[Comparative studies on biologic availability and pharmacokinetics of bromazepam in tablets]O von Stetten, K D Rehm, E Fenzl, et al.
Pageof 2